The flow-volume loop is a test of ventilatory function in which a graphic recording of maximal flow rates is dispiayed at all lung volumes during a maximal effort forced expiratory and inspiratory vital capacity maneuver. The test is errsy to demonstrate, administer, and analyze. Pulmonary diseases produce characteristic flow-volume loop abnormalities. The visualization of abnormalities and calculation of instantaneous Bow rates at specific lung volumes mdce this test useful in screening for pulmonary disease, assessing the pulmonary effect of drugs, and following progression or regression of pulmonary disease. Normal standards for loop vital capacity, volume expired or inspired to achieve peak flow rate, expiratory and inspiratory peak flow rates, flow rates at 25 percent, 50 percent, and 75 percent of the vital capacity, and prediction equations for these indices are reported. Patterns of abnormality detected in the chronic obstructive pulmonary diseases, bronchial asthma, chronic bronchitis, and pulmonary emphysema are described. Alteration of position from sitting to standing or supine for performance of the test did not significantly alter mean flow-volume loop indices.
A o u r before clinical symptoms or signs of disease due to a large pulmonary reserve. Since pulmonary function abnormalities are usually associated with pulmonary pathology, early detection of abnormal pulmonary function aids diagnosis and leads to therapy which may halt progression of disease. Single indices of pulmonary function have limited value in screening for pulmonary disease, and it is not practical to perform multiple pulmonary function tests as part of a screening evaluation. The flow-volume loop, a ventilatory test easy to demonstrate, administer, and with characteristic abnormalities in pulmonary disease, fulfills criteria needed in effective screening programs. This report gives the normal value for specific indices calcu- lated from the flow-volume loop and prediction equations. Characteristic abnormalities of the flowvolume loop are described for patients with bronchial asthma, chronic bronchitis, and pulmonary emphysema. The effect of change in posture on the flow-volume loop is assessed.
The flow-volume loop is a test of ventilatory function in which velocity of airflow is plotted against volume during a maximal effort expiratory and inspiratory vital capacity maneuver. Two hundred and forty-seven normal subjects, 11 patients with pulmonary emphysema, 10 patients with chronic bronchitis, and 10 patients with bronchial asthma were studied. Patients with bronchial asthma performed the test before and after administration of the bronchodilator, isoproterenol. Subjects were chosen for study after an evaluation which included a medical history, an extensive respiratory disease review,' physical examination, pulmonary function assessment, and chest roentgenograms. Pulmonary fi~nc-tion tests in the normal volunteers included measurement of the vital capacity (VC ), forced expiratory volume, one second ( F E V , ) , forced expiratory volume three seconds physical examination, pulmonary function, or chest roentgenogram. Existing nonnal standards were used to assess nornialcy of pulmonary function."-Standard statistical techniques were used to derive prediction formulae for normal indices. Patients with chronic obstructive pulnionary disease had additional pnlnionary function and roentgenographic evaluation in order to better define their specific disease.6 \lean values for indices measured in patients with chronic bronchitis, bronchial asthma, and emphysema were compared to niean values of nomial subjects.
?
To determine the reproducibility of the flow-volume loop, a a selected sample of nom~al subjects and patients with obstructive pulmonary disease performed ten consecutive tcsts with a three-minute rest period between efforts. The I(n)p was perfor~iled sitting, standing, and supine in a selected 
INSPIRATION
demonstrated to all patients. Instructions were given to take 3 a cu)mplete breath in, perfomi a maximal effort complete expiration into a wedge (460 bled Science) spiro~neter, and 2 then a rnaximal effort complete inspiration from the spirometer. All patients practiced the maneuver at least once before performing two flow-volume loops which were recorded. Signals of volunie and flow rate taken from the spirometer were recorded on the x and y axes of a memory oscilloscope and then photographed. Calculations were performed for the expiratory VC and in expiration and inspiration for the FIGURE 1. Flow-volume loop derived from mean data of 149 volr~nle of air expired or inspired to achieve peak flow rate normal men. peak flow rate and flow rates at 25 percent, 50 ( V to peak flow rates ( P F R ) , and flow rates at 25 percent, and 75 percent of the vital capacity are indicated for percent, 50 percent, and 75 percent of VC maneuver (Fig 1) . expiration and inspiration,
RESULTS
indices. Since there is visual display of the test Analysis of variance for indices measured from results, the similarity or dissimilarity between two ten cor~secutive flow-volume loops showed that only flow-volume loops can be assessed at the completwo similar flow-volume loops per subject would tion of the test, allowing additional flow-volume need to be performed in order to obtain reliable loops to be performed when needed. wt (11,s) RSA (mP) sv<: (1) THE FLOW VOLUME LOOP Tables 1 and 2 . In the normal subjects measurements of VC, FEV1, FEV3, and M W compared favorably to normal standards for these indices (Tables 1 and 2 ) .2-5 Mean flow-volume loop indices of women were lower than those of men, necessitating separate prediction equations for each sex ( Table 3 ) . Statistical analysis performed with normal subjects revealed no significant change in flow volume loop indices related to position (Table 4 ) .
Mean values of flow-volume loop indices of the ten patients with chronic bronchitis (nine men and one woman) were significantly lower than the comparable mean values of normal subjects (Fig  2) . In patients with chronic bronchitis, the decrease in expiratory flow rates was larger at PFR, 25 percent, and 50 percent of VC than at 75 percent of VC. Inspiratory flow rates were reduced at PFR, 25 percent, 50 percent, and 75 percent of the VC (Table 5 ) . Mean values of flow-volume loop indices of ten patients with bronchial asthma were significantly lower than the comparable mean values of normal subjects. The pattern of decrease for inspiratory and expiratory flow rates in patients with bronchial asthma was similar to that of patients with chronic bronchitis (Table 5 ). Indices in patients with bronchial asthma reverted toward normal after isoproterenol administration (Fig 3 ) . significantly lower in patients with pulmonary emphysema than in normal subjects or patients with chronic bronchitis or bronchial asthma (Table 5 , Fig 4) . Statistical analysis of results performed with patients with pulmonary emphysema seated, supine, or standing revealed no significant change in flow volume loop indices related to position ( Table  4 ) .
Mean values of flow-volume loop indices were
The flow-volume loop is a ventilatory test which is reproducible, easy to demonstrate, administer, monitor, and calculate. Availability of prediction equations for normalcy of indices calculated from the flow-volume loop using simple anthropomorphic data makes the test useful in screening for pulmonary disease and assessing progression or regression of disease. Prediction equations were derived for VC, and points on the expiratory and inspiratory curve at 25 percent, 50 percent, and 75 percent of VC, as well as volume expired from total lung capacity or inspired from residual volume to achieve peak flow rate ( Table 3 ) . The prediction equations derived were comparable to those for similar indices derived by other investigator^.*-^* 7- 9 Cooperation and effort are needed for proper performance of the flow-volume loop and the lack of either will have a greater effect on flow rates at higher lung volumes than at lower lung volumes because the former are effort-dependent. In the absence of parenchymal pathology, central nervous system depression, muscle atrophy, neuromuscular weakness, fatigue, and conditions affecting chest wall motion will result in a greater decrease in flow rates at higher lung volumes than at lower lung volumes. Lung volumes below about two-thirds of he clinical usefulness of the flow-volume loop emanates from visual analysis of expiratory and inspiratory flow rates at high, mid, and low lung volumes. Patients initiated the recorded test by performing a complete inspiration of room air, exhaling a maximal forced complete breath into the spirometer, and then inhaling a maximal forced complete breath from the spirometer. Flow limitation in large airways would reduce expiratory flow rates at all lung volumes; whereas, flow limitation in medium-sized airways would decrease flow rates mainly at the mid portion of the expiratory flow-volume Ioop. This is seen in patients with chronic bronchitis, a disease affecting mainly medium-sized airways ( Fig 2 ) . A single index useful in assessing the presence and severity of chronic bronchitis is the instantaneous flow rate at 50 percent of VC (the instantaneous maximal midexpiratory flow rate). Flow limitation in small airways reduces flow rates at low lung volumes more than at high and mid lung volumes. In left heart failure small airways are frequently narrowed b y the increased interstitial pressure secondary to transudation of fluid. This leads to an increase in frictional resistance to a i d o w in small airways and a decrease in expiratory flow rates at low lung volumes. 15 The pattern of reduction in flow rates for patients with bronchial asthma was similar to that seen for patients with chronic bronchitis; however, only in patients with bronchial asthma did values for expiratory and inspiratory flow rates revert toward normal following isoproterenol administration ( Fig. 3 ) .
CHEST
Flow-volume loop indices were more abnormal in patients with pulmonary emphysema than in patients with either chronic bronchitis or bronchial asthma (Fig 4) .
Abnormalities of indices calculated from the flowvolume loop separate normal subjects from patients with chronic obstructive pulmonary disease. The rapid visual display of the flow-volume loop and of the abnormalities characteristic of chronic obstructive pulmonary disease makes this ventilatory test useful in screening. Ease of administration, performance, and calculation of the flow-volume loop make serial analysis valuable in individual patients to assess their pulmonary response to drugs or the progression or regression of their pulmonary disease.
